TerminatedNot Applicable

A Tailored Screening and Smoking Cessation Program for the LGBTQ Community of Seattle

Stopped: Terminated due to end of funding. Enrollment sufficient to evaluate primary and secondary outcomes measures.

United States53 participantsStarted 2022-06-06

Plain-language summary

This clinical trial develops a tailored screening and smoking cessation program for the lesbian, gay, bisexual, transgender (trans) and queer (LGBTQ) community of Seattle, Washington. A lung cancer screening program may help LGTBQ people who smoke overcome unique barriers that keep them from receiving preventive care, and constantly facing healthcare discrimination. Members of the LGBTQ community have historically smoked at higher rates than the general population and thus could benefit greatly from targeted efforts to improve lung cancer screening and smoking cessation implementation.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * AIM 1 MEDICAL PROVIDER OF LGBTQ PATIENTS: Age minimum of 18 * AIM 1 MEDICAL PROVIDER OF LGBTQ PATIENTS: Affiliation with Cancer Consortium, Seattle's LGBTQ Center, or other organization serving LGBTQ persons * AIM 1 MEDICAL PROVIDER OF LGBTQ PATIENTS: Identifies as providing primary care or specialty care to largely LGBTQ population (doctor of medicine \[MD\], registered nurse \[RN\], physician assistants \[PA\], advanced registered nurse practitioner \[ARNP\]) * AIM 1, COMMUNITY ORGANIZATION LEADERS: Age minimum of 18 * AIM 1, COMMUNITY ORGANIZATION LEADERS: Broadly defined as "community leader" (i.e. leadership in Seattle-area volunteer, philanthropic, community service groups) in discussions with with community-based participatory research (CBPR) partners * AIM 2: Current cigarette smoker (defined as actively smoking within the last 6 months, this is consistent with (c/w) standard and Seattle Cancer Care Alliance (SCCA) definition of "current smoker") or former cigarette smoker * AIM 2: Aged 50-80 years * AIM 2: At least 20 pack-year smoking history * AIM 3: Identify as a member of the LGBTQ community * AIM 3: Eligible for no-cost sharing LCS based on United States Preventive Services Task Force (USPSTF) criteria * As of Jan 2022: aged 50-80 years, at least 20 pack-year smoking history, and currently smoke tobacco cigarettes \[as this intervention is based around current cigarette smokers (as defined above)\], former cigarette smokers not included…

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Number of lesbian, gay, bisexual, transgender (trans) and queer (LGBTQ) community stakeholders who participate in the Aim 1 interviews/focus groups (Aim 1)

Timeframe: Up to 3 months

Number of LBGTQ community members who participate in the Aim 2 focus groups (Aim 2)

Timeframe: Up to 9 months

Acceptability of patient navigation and smoking cessation interventions (Aim 3)

Timeframe: Up to 12 months

Patient satisfaction with navigator throughout navigation and smoking cessation interventions (Aim 3)

Timeframe: Up to 12 months

Effectiveness of navigation visit(s): knowledge (Aim 3)

Timeframe: Up to 12 months

Effectiveness of navigation visit(s): smoking cessation (Aim 3)

Timeframe: Up to 12 months

Trial details

NCT IDNCT05304390

SponsorFred Hutchinson Cancer Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-10-28

View on ClinicalTrials.gov More Lung Carcinoma trials

Plain-language summary

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Number of lesbian, gay, bisexual, transgender (trans) and queer (LGBTQ) community stakeholders who participate in the Aim 1 interviews/focus groups (Aim 1)

Timeframe: Up to 3 months

Number of LBGTQ community members who participate in the Aim 2 focus groups (Aim 2)

Timeframe: Up to 9 months

Acceptability of patient navigation and smoking cessation interventions (Aim 3)

Timeframe: Up to 12 months

Patient satisfaction with navigator throughout navigation and smoking cessation interventions (Aim 3)

Timeframe: Up to 12 months

Effectiveness of navigation visit(s): knowledge (Aim 3)

Timeframe: Up to 12 months

Effectiveness of navigation visit(s): smoking cessation (Aim 3)

Timeframe: Up to 12 months